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Objective.—Exploring the pathophysiological changes in transient receptor potential vanilloid 1 (TRPV1) receptor of
the trigeminovascular system in high-fat, high-sucrose (HFHS) diet-induced obesity of experimental animals.
Background.—Clinical and experimental observations suggest a link between obesity and migraine. Accumulating evi-
dence indicates that metabolic and immunological alterations associated with obesity may potentially modulate trigemino-
vascular functions. A possible target for obesity-induced pathophysiological changes is the TRPV1/capsaicin receptor which
is implicated in the pathomechanism of headaches in a complex way.
Methods.—Male Sprague-Dawley rats were fed a regular (n5 25) or HFHS diet (n5 26) for 20 weeks. At the end
of the dietary period, body weight of the animals was normally distributed in both groups and it was significantly higher
in animals on HFHS diet. Therefore, experimental groups were regarded as control and HFHS diet-induced obese
groups. Capsaicin-induced changes in meningeal blood flow and release of calcitonin gene-related peptide (CGRP) from
dural trigeminal afferents were measured in control and obese rats. The distribution of TRPV1- and CGRP-
immunoreactive meningeal sensory nerves was also compared in whole mount preparations of the dura mater. Metabolic
parameters of the animals were assessed by examining glucose and insulin homeostasis as well as plasma cytokine
concentrations.
Results.—HFHS diet was accompanied by reduced food consumption and greater fluid and energy intakes in addition
to increased body weight of the animals. HFHS diet increased fasting blood glucose and insulin concentrations as well as
levels of circulating proinflammatory cytokines interleukin-1b and interleukin-6. In obese animals, dural application of the
archetypal TRPV1 agonist capsaicin resulted in significantly augmented vasodilatory and vasoconstrictor responses as com-
pared to controls. Diet-induced obesity was also associated with enhanced basal and capsaicin-induced CGRP release from
meningeal afferents ex vivo. Except for minor morphological changes, the distribution of dural TRPV1- and CGRP-
immunoreactive afferents was similar in control and obese animals.
Conclusions.—Our results suggest that obesity induced by long-term HFHS diet results in sensitization of the trigemi-
novascular system. Changes in TRPV1-mediated vascular reactions and CGRP release are pathophysiological alterations
that may be of relevance to the enhanced headache susceptibility of obese individuals.
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INTRODUCTION
Migraine is a common and disabling neurologi-
cal disorder that seems to be potentiated by obesi-
ty. Obese persons have increased risk of developing
migraine and may suffer from more frequent and
severe headache attacks.1 Clinical and experimental
observations suggest multiple links between the
pathophysiology of obesity and the primary head-
ache migraine,2 among which the role of calcitonin
gene-related peptide (CGRP) released from trigem-
inal afferents might be of particular relevance.3
CGRP is regarded as one of the key mediators
in both nociceptive transmission and meningeal
arterial vasodilatation that are critical pathophysio-
logical components of headaches.4-6 Current
migraine therapies are based on reducing CGRP
effects by either inhibiting its release from menin-
geal nociceptors (triptans acting on 5-HT1B/1D
receptors) or blocking the CGRP receptor (non-
peptide CGRP receptor antagonists “gepants”).7
Administration of humanized monoclonal anti-
bodies targeting CGRP or its receptor appears also
a promising new strategy in the therapy of
migraine.8,9 However, available anti-migraine drugs
are not without limitations. Triptans are ineffective
in a significant percentage of migraine sufferers,
their frequent use may lead to medication overuse
headache and they are contraindicated in patients
with risk factors for cardiovascular disease that are
often associated with obesity.10,11 Furthermore, the
development of gepants has been interrupted due
to side effects. Thus, migraine remains a condition
calling for additional therapeutic approaches.12
Chemosensitive primary afferent neurons which
express the transient receptor potential (TRP) vanil-
loid 1 (TRPV1) receptor and may also co-express
other members of the TRP receptor family represent
a unique population of trigeminal ganglion neu-
rons.13-17 They play a fundamental role in nocicep-
tion and their peptidergic population releasing
CGRP and/or substance P mediates neurogenic vas-
cular reactions in the meninges.13,18-20 Chemosensi-
tive nociceptors represent a promising target for
novel migraine therapeutics.21,22 TRPV1 is a molecu-
lar integrator of various nociceptive stimuli. It can
be activated by low pH, noxious heat and different
endogenous and exogenous agents, such as endova-
nilloids (eg, anandamide) and capsaicin, or alcohol,
a well-known headache trigger.19,23,24 Factors related
to tissue damage or inflammation may sensitize the
receptor by increasing the probability of channel
opening on stimulation.25,26 Enhanced activity of the
trigeminovascular nociceptive pathway may result
from sensitization of TRPV1 receptors.27 Prolonged
activation of trigeminal afferents may also increase
the excitability of second order neurons in the cau-
dal trigeminal nucleus.28 Processes of peripheral and
central sensitization are considered as significant
pathophysiological mechanisms of primary head-
aches. Earlier findings from our laboratory have also
proved a capsaicin-induced vasoconstrictor response
in dural blood vessels that was present even after
functional degradation of trigeminal chemosensitive
afferents.18 Expression of TRPV1 receptors in a
wide variety of non-neuronal tissues including
smooth muscle cells in different vascular beds may
explain the vasoconstrictor effect of capsaicin.29
Modification of neuronal and vascular TRPV1
receptor function resulting in altered activity of the
trigeminovascular system may represent a link
between obesity and migraine pathophysiology.
Chronic expansion of adipose tissue producing bio-
active molecules with immunoregulatory functions,
oxidative and nitrosative stress and microvascular
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dysfunction are pathophysiological correlates of
obesity30 that may modulate trigeminovascular
functions as well.31,32 These interrelated disturban-
ces may influence TRPV1 channel function leading
to enhanced sensitivity of the trigeminal nociceptive
pathway. Recent experimental studies demonstrat-
ed an increased capsaicin-induced activity of the tri-
geminal pain pathway in obese mice.33,34
The present experiments were initiated to
examine the effects of high-fat, high-sucrose
(HFHS) diet-induced obesity on the function of tri-
geminovascular nociceptive afferents in the rat.
Therefore, TRPV1-dependent meningeal nociceptor
function was evaluated in control and obese rats by
studying capsaicin-evoked meningeal vascular
responses, the ex vivo release of CGRP from dural
afferents and the immunohistochemical demonstra-
tion of TRPV1- and CGRP-immunoreactive nerves
of the dura mater. The plasma levels of proinflam-
matory cytokines as well as glucose and insulin
homeostasis were also determined in control and
obese animals to gain further insight into possible
mechanisms of obesity-related trigeminal neurovas-
cular alterations.
METHODS
Animals and Diet.—Experiments were approved
by the Ethical Committee for Animal Care of the
University of Szeged and the University of Debre-
cen. Study procedures were carried out in accor-
dance with the Directive 2010/63/EU of the
European Parliament. All efforts were made to
minimize the number of animals used and their
suffering.
Male Sprague-Dawley rats (6 weeks old, weigh-
ing 150-170 g, Charles River Laboratories, Hunga-
ry) were housed in an environmentally controlled
room (12-hours light/dark cycle, 226 28C, 50-70%
relative humidity) and fed according to our recently
published protocol.35 Animals in the control group
(n5 25) received a regular diet containing standard
rodent chow (3.20 kcal/g, 59% carbohydrate, 32%
protein, 9% fat; diet code: S8106-S011 SM R/M-
Z1H, ssniff Spezialdi€aten GmbH, Germany) and
tap water. Another group of animals was placed on
an HFHS diet (n5 26) consisting of high-fat chow
(4.56 kcal/g, 35% carbohydrate, 20% protein, 45%
fat; diet code: 824018, Special Diets Services, UK)
and 5% sucrose solution made with tap water.
Body weight, food and fluid intake of the animals
were measured regularly and daily calorie intake
was calculated. Diets were provided ad libitum for
20 weeks. All experiments were carried out after
the completion of the dietary treatment period in
26-week-old animals.
Analysis of Fasting Blood Glucose, Plasma
Insulin, Interleukin-1b (IL-1b), and Interleukin-6
(IL-6) Concentrations.—Following an overnight
fast, rats were anesthetized with intraperitoneally
(i.p.) administered thiopental sodium (100 mg/kg,
Sandoz, Austria). The carotid artery was cannu-
lated for blood sampling. After a short stabilization
period, blood glucose was determined with a gluc-
ometer (Accu-Chek, Roche Diagnostics, Hungary,
detection range: 0.6-33.3 mmol/L) and additional
samples were taken to Eppendorf cups. Blood sam-
ples were centrifuged for 2 minutes at 10,000g and
48C. The plasma was aliquoted, frozen and stored
at 2708C for later analysis. Plasma concentration of
insulin was measured by immunoradiometric assay
(IRMA) using an insulin IRMA kit (Institute of
Isotopes, Hungary, detection range: 8.6-861 lU/mL,
sensitivity: 2.8 lU/mL). IL-1b (Thermo Scientific,
USA, detection range: 25.6-2500 pg/mL, sensitivity:
12 pg/mL) and IL-6 (Life Technologies, USA, detec-
tion range: 23.5-1500 pg/mL, sensitivity: 5 pg/mL)
levels were assessed by enzyme-linked immunoassay
(EIA) specific for rat according to the manufac-
turer’s instructions.
In Vivo Recordings of Meningeal Blood
Flow.—Changes in meningeal blood flow were mea-
sured in an open cranial window preparation.18,36
Control and obese rats were anesthetized with thio-
pental sodium (100 mg/kg, i.p.). The femoral artery
was cannulated on one side for the measurement of
systemic blood pressure. The body temperature of
the animals was recorded with a thermoprobe
inserted into the rectum and was kept at 37-37.58C
with a feedback-controlled heating pad. The tra-
chea was cannulated to allow spontaneous breath-
ing throughout the experiment. The head of the
animal was fixed in a stereotaxic frame and the
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skin overlying the skull was opened. A cranial win-
dow was drilled into the parietal bone to expose
the dura mater. Blood flow was recorded with a
needle-type probe of a laser Doppler flowmeter
(Perimed, Sweden) positioned over a branch of the
middle meningeal artery lying distant from visible
cortical blood vessels.
The exposed dura mater in the cranial window
was covered with 40 lL of synthetic interstitial fluid
(SIF) containing (in mM): 135 NaCl, 5 KCl, 1
MgCl2, 5 CaCl2, 10 glucose and 10 Hepes, pH 7.4.
Stimulation of the dura mater was performed by
topical application of capsaicin (100 nM and 10
lM, Sigma-Aldrich, Germany), CGRP or histamine
(both at 100 lM, Sigma-Aldrich) at a volume of 40
lL. Solutions were removed after 5 minutes and
the dura mater was washed repeatedly with SIF to
allow the blood flow to return to the basal level.
Blood flow was measured in perfusion units (PU).
Data on meningeal blood flow and systemic blood
pressure were processed with the Perisoft program
(Perimed, Sweden). Basal blood flow was
determined as the mean flow during a 3-minute
period prior to the stimulation of the dura mater.
Percentage changes in meningeal blood flow in
response to capsaicin, CGRP and histamine were
determined as mean flow values within the 5-
minutes application period calculated separately at
one-minute intervals relative to the basal flow. A
stock solution of capsaicin (32 mM) was prepared
with the aid of 6% ethanol and 8% Tween 80 in
saline and was further diluted with SIF. All the oth-
er drugs were dissolved in SIF immediately before
use.
Measurement of CGRP Release in Ex Vivo Dura
Mater Preparation.—An ex vivo rat dura mater
preparation was used to measure basal and stimu-
lated CGRP release from meningeal afferents.37
Control and obese rats were decapitated following
deep anesthesia with thiopental sodium (150 mg/kg
i.p.). After removing the skin and the muscles, the
skull was divided into halves along the midline. The
cerebral hemispheres were removed, skull halves
were washed at room temperature for 30 minutes
in SIF, then placed in a humid chamber and the
cranial fossae were filled with 300 lL SIF. Samples
of the superfusate were collected with a micropi-
pette at periods of 5 minutes for CGRP measure-
ment. A control sample was taken to determine
basal CGRP release. Then the dura mater was
stimulated with capsaicin at concentrations of 10
and 100 nM. 100 lL of samples diluted with 25 lL
EIA buffer were placed into Eppendorf cups and
immediately frozen at 2708C for subsequent analy-
sis. EIA method was used for CGRP determination
(SPI-Bio, Bertin Pharma, France). The CGRP con-
centrations of the superfusates were expressed in
pg/mL. Changes induced in CGRP release by cap-
saicin were expressed as percentage changes rela-
tive to the basal release.
Immunohistochemistry.—The distribution of
TRPV1- and CGRP-immunoreactive nerve fibers
was studied in dural whole mount preparations of
rats not used in in vivo blood flow recordings or in
ex vivo CGRP release experiments previously. Con-
trol and obese animals were anesthetized deeply
with thiopental sodium (150 mg/kg, i.p.) and per-
fused transcardially with physiological saline fol-
lowed by 4% paraformaldehyde in phosphate
buffer (pH 7.4). The skin and muscles of the skull
were removed and the skull was divided into halves
along the sagittal suture. After removing the brain,
samples of the dura mater containing branches of
the middle meningeal artery were cut out, postfixed
for 2 hours in the same fixative and processed for
staining with the indirect immunofluorescence tech-
nique using a rabbit polyclonal antiserum raised
against the TRPV1 receptor (1:500, Alomone Labo-
ratories, Israel) in combination with a monoclonal
mouse anti-CGRP antibody (1:500, Sigma-Aldrich,
Germany). IgGs labeled with Cy3 and DL488 were
used as secondary antibodies (both 1:500, Jackson
Immunoresearch Laboratories, USA). Whole
mount preparations of the dura mater were exam-
ined under a confocal fluorescence microscope
(ZEISS LSM 700, Germany).
Statistics.—All values were expressed as means6
SEM. Statistical analysis of the data was performed
using Statistica 12 (StatSoft, USA). In both dietary
groups, normality in terminal body weight was
proved by the Shapiro-Wilk test. For the statistical
comparisons of CGRP and cytokine concentrations,
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meningeal blood flow changes, food and fluid
intake of the animals the Student’s t-test was used
for group sizes of n 10 and the Mann-Whitney U-
test for independent measurements of group sizes
n< 10. One-way ANOVA followed by the Bonfer-
roni test was used to compare metabolic parameters
of the animals. A probability level of P< .05 was
regarded as statistically significant.
RESULTS
Characterization of the Diet-Induced Obesity
Model.—On average, the HFHS group of animals
consumed smaller quantities of food (P< .001) and
greater amount of fluid (P< .001) than animals fed
with a regular diet. The mean daily caloric intake
of HFHS rats significantly exceeded the control
group (P< .001), resulting in a significantly higher
body weight at the end of the dietary period
(616.56 11 g in control and 740.56 15 g in obese
animals, P< .001, n5 17 for both groups, Fig. 1).
Diet-induced obesity led to elevations in fasting
blood glucose (5.756 0.13 vs 6.546 0.33 mmol/L,
P5 .049, n5 8 and 9) and plasma insulin concentra-
tions (17.466 3.31 vs 48.516 8.67 lU/mL, P5 .006,
n5 8 and 9) in addition to circulating levels of the
proinflammatory cytokines IL-1b (59.046 2.99 vs
170.046 23.78 pg/mL, P< .001, n5 8 and 9) and
IL-6 (56.396 2.15 vs 114.466 11.32 pg/mL,
P< .001, n5 8 and 9) as indicated recently35 (Fig.
2). Concentration of all blood markers were above
the lower limit of detection. Since body weights
indicating the obesity status of the animals were
different and normally distributed, we regarded the
dietary groups accordingly as control and HFHS
diet-induced obese groups.
Diet-Induced Obesity Potentiates Increases in
Meningeal Blood Flow Elicited by TRPV1
Activation.—The basal blood flow values were in
the same range in control and obese rats amounting
to 245.26 18.1 and 244.16 19.6 PU (P5 .96),
respectively. In control rats, topical administration of
capsaicin at 100 nM concentration induced a moder-
ate increase in meningeal blood flow reaching signifi-
cance in the last two minutes of the 5 minutes
application period (P5 .048 and .035, respectively,
n5 8). Blood flow increasing effect of the same cap-
saicin concentration was more robust in obese ani-
mals throughout the whole application period, it
reached 206 3.1% increase in the last minute
(P .023, n5 9). This increase significantly exceeded
the effect measured in control rats (P .049, Fig.
3A,B). Administration of capsaicin at 10 lM
reduced meningeal blood flow in both groups of ani-
mals. In control animals, decrease in meningeal
blood flow varied in the range from 4.76 2.7% to
2.76 2.5% (P .33, n5 6), while this range was
14.56 2.9 to 86 2.8% (P .036, n5 6) in obese rats.
Blood flow reducing effect of 10 lM capsaicin was
significantly stronger in obese animals from the sec-
ond to the fourth min compared to controls
(P .037, Fig. 3A,C). Histamine and CGRP acting
directly on endothelial- or smooth muscle cells of
Fig. 1.—Average daily food, fluid, and calorie intakes of rats maintained on regular or HFHS diet (n5 17 in both groups).
*Statistically different from the control.
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blood vessels induced significant increases in menin-
geal blood flow in both control (P .015, n5 8
both) and obese (P .035, n5 8 and 10, respective-
ly) rats. No difference regarding the vasodilatation
induced by histamine (P .98) and CGRP (P .92)
administrations could be observed between control
and HFHS diet-induced obese animals (Fig. 3D,E).
Systemic blood pressure of animals was in the
same range as we have published recently.35 It was
1386 12 and 1426 18 mmHg in control and obese
rats, respectively. Drugs administered topically to
the dura mater failed to influence systemic blood
pressure.
Diet-Induced Obesity Enhances Basal and
TRPV1-Mediated CGRP Release.—In the ex vivo
dura mater preparation of obese animals we mea-
sured a significantly increased basal CGRP release.
Unstimulated CGRP concentration was 166 1.5 in
Fig. 2.—Effect of diet-induced obesity on plasma concentrations of (A) interleukin-1b (IL-1b), interleukin-6 (IL-6), (B) fasting
blood glucose, and (C) fasting plasma insulin concentrations. The number of experiments is indicated in the bars. *Statistically
different from the control.
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control and 42.16 6.6 pg/mL in obese rats
(P5 .005). Stimulation with capsaicin significantly
enhanced the release of CGRP from meningeal
afferents in skull preparations obtained from both
control and obese animals. Capsaicin at a concen-
tration of 10 nM elevated CGRP release to
34.76 2.3 pg/mL (196.66 21.2% of basal release,
P< .001, n5 7) and at 100 nM concentration to
75.66 7 pg/ml (612.76 58.9% of basal release,
P< .001, n5 6) in rats maintained on a regular diet.
In obese animals, capsaicin at 10 nM concentration
increased the release of CGRP to 1206 27.6 pg/mL
Fig. 3.—Effect of TRPV1 receptor activation on meningeal blood flow. (A) Original recordings and (B-E) statistical evaluation
of blood flow-modifying effects of topical applications of capsaicin (100 nM and 10 lM), histamine and CGRP (100 lM both).
*Statistically different from the basal flow; #Statistically different from the control.
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(300.16 60.1% of basal release, P5 .004, n5 11)
and at 100 nM to 358.16 95.5 pg/mL (853.16 76%
of basal release, P5 .004, n5 11). HFHS diet-
induced obesity resulted in a significantly greater
CGRP release in response to both capsaicin con-
centrations as compared with the control (P5 .027
and P< .048, respectively, Fig. 4).
Effect of HFHS Diet on TRPV1- and CGRP-
Immunoreactive Nerve Fibers of the Dura Mater.—In
the dura mater of control animals TRPV1- and
CGRP-immunoreactive nerve fibres were distribut-
ed over the whole supratentorial dura mater. Many
TRPV1-immunoreactive nerves were seen running
in small nerve bundles in association with dural
blood vessels. Single axons were also observed in
avascular regions of the meningeal tissue, ie, in
areas at a distance from larger blood vessels, where
they formed loose nerve plexuses. CGRP was colo-
calized with TRPV1 in most of these nerve fibres.
Although in whole mount dura preparations of
obese rats, distribution of TRPV1- and CGRP-
immunoreactive afferents was similar to that seen
in control dura mater preparations, many single
axons showed characteristic changes. While CGRP-
immunoreactivity was distributed evenly in the
afferents of control dura, in whole mounts of obese
animals the immunoreactivity was observed in the
form of a string of pearls (Fig. 5).
DISCUSSION
This study was undertaken to study the effect
of a state of obesity on trigeminovascular TRPV1
receptor function, a pivotal component of headache
mechanisms. Therefore, rats were fed on an HFHS
Western-type diet to create a metabolic and immu-
nological condition that may also characterize
obese headache sufferers.
HFHS diet altered the eating behavior of ani-
mals indicating that dietary treatment influenced
processes involved in the regulation of food intake
and energy balance.38 The lower food consumption
and higher fluid and calorie intakes in HFHS-fed
animals are in agreement with previous reports in
which the energy density and palatability of the
diet were manipulated in a similar way.39-41 The
accumulation of adipose tissue was accompanied by
impairments in glucose and insulin homeostasis and
a low-grade systemic inflammatory milieu. The pre-
sent findings demonstrate that our animal model of
diet-induced obesity possessed many of the meta-
bolic alterations that have been previously sug-
gested to be associated with obesity as well as with
the pathophysiology of migraine.42-44
The function of trigeminal nociceptors can be
assessed by studying vascular responses in relation
to neuropeptide release from dural afferents. Previ-
ous studies have confirmed that the meningeal vaso-
dilatory action of capsaicin is mediated by the
activation of TRPV1 receptors in chemosensitive
afferents and the consequent release of CGRP from
their peripheral endings.18 Changes in metabolic
conditions may modify the functionality of trigemi-
nal chemosensitive neurons. Meningeal TRPV1
expressing nerves in streptozotocin-induced diabetic
rats were found impaired showing reduced neuro-
genic sensory vasodilatation, decreased capsaicin-
evoked CGRP release and reduction in the number
of TRPV1-immunoreactive nerve fibers of the dura
mater.45 This study provides the first direct evidence
that diet-induced obesity in rats leads to augmented
Fig. 4.—TRPV1 receptor activation-induced release of
CGRP from meningeal afferents. CGRP concentrations (pg/
mL) measured after topical application of SIF and capsaicin
(10 and 100 nM). The number of experiments is indicated in
the bars. *Statistically different from the basal release; #Sta-
tistically different from the control.
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vasodilatory responses in meningeal blood vessels
following activation of trigeminal TRPV1 receptors.
Enhanced vascular reactions were selective for cap-
saicin since neither CGRP- nor histamine-induced
vascular reactions in diet-induced obese animals dif-
fered from the control. Measurement of capsaicin-
induced CGRP release in ex vivo dura mater prepa-
rations of the obese rats indicates that an increased
CGRP release from meningeal nociceptive afferent
nerves may account for the enhanced capsaicin-
induced vasodilatation. The current results are in
accordance with recent studies in our laboratory that
furnished evidence for an enhanced CGRP-mediated
neurogenic sensory vasodilatation in the meninges of
obese animals on the activation of transient receptor
potential ankyrin 1 (TRPA1) channels by the envi-
ronmental irritant acrolein.35 However, TRPA1
receptors are expressed only in a subset of TRPV1-
positive chemosensitive primary afferent nerves.46
Although most studies dealing with headache
mechanisms focus on trigeminal peptidergic
afferents, it should be emphasized that a large pop-
ulation of TRPV1 expressing neurons does not con-
tain neuropeptides.47 Non-peptidergic nociceptive
primary sensory neurons can be identified through
their binding of the plant lectin, Griffonia simplici-
folia isolectin B4 (IB4). The possible role of non-
peptidergic nociceptive afferents in the pathome-
chanism of headaches remains to be elucidated. It
is conceivable that peptidergic and non-peptidergic
TRPV1-expressing neurons provide parallel affer-
ent pathways for the transmission of nociceptive
signals.21 Activation of peptidergic neurons induces
increases in meningeal blood flow but release of
CGRP from their central terminals in the trigemi-
nal nucleus has presumably only a presynaptic mod-
ulatory effect controlling the neurotransmitter
release in other populations of primary afferents.48
Non-peptidergic TRPV1 expressing trigeminal neu-
rons fail to contribute to local neurogenic vascular
reactions in the dura mater, but they may provide a
direct transmission of nociceptive signals to second
Fig. 5.—Immunohistochemical photomicrographs showing the distribution of TRPV1- (A, D) and CGRP- (B, C, E, F) immu-
noreactive nerve fibers in the dura mater of control (A-C) and HFHS diet-induced obese (D-F) rats. Distribution of TRPV1-
and CGRP-immunoreactive afferents is similar in the dura mater preparations of control and obese animals. The pearl-like
distribution of CGRP-immunoreactivity may be the morphological correlate of enhanced CGRP release in obese animals.
Scale bar on E represents 50 lm and applies for A, B, D, and E; scale bar on F represents 25 lm and applies for C and F,
MMA5 branch of the middle meningeal artery. [Color figure can be viewed at wileyonlinelibrary.com]
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order neurons of the pain pathway.21 Obesity-
related factors that alter the function of TRPV1
receptors in CGRP-containing meningeal afferents
may also have the potential to affect TRPV1 in
non-peptidergic trigeminal sensory neurons.
Earlier observations in our laboratory demon-
strated a capsaicin-induced vasoconstriction in men-
ingeal blood vessels that appeared parallel with the
CGRP-induced vasodilatation and was independent
of neural processes.18 The mechanism of capsaicin-
induced vasoconstriction is not completely clarified.
It is generally regarded as a direct vascular action
of capsaicin,49-51 but contribution of TRPV1 recep-
tors expressed in vascular smooth muscle cells can-
not be excluded.29 Our present findings indicated
that in dural arteries both the vasodilatory and the
vasoconstrictor actions of capsaicin were enhanced
in obese animals.
The mechanisms responsible for obesity-
associated changes in capsaicin-evoked meningeal
vascular responses and CGRP release are likely to
involve complex dose- and time-dependent interac-
tions among multiple causative factors, which may
appear already at an early stage of the dietary peri-
od enabling them to act chronically on the trigemi-
novascular system. High-fat diet has been shown to
increase calcium influx in both cultured trigeminal
ganglion neurons and vascular smooth muscle cells
of cerebral arteries,34,52 therefore alterations in cal-
cium homeostasis in trigeminal primary afferents
and meningeal vasculature could potentially con-
tribute to altered neurocrine and vasoconstrictor
responses under basal conditions and to stimulation
with capsaicin in obese animals.
The increased basal and capsaicin-induced
CGRP release that was measured in the ex vivo
dura mater preparation of HFHS diet-induced obese
animals may result from a sensitization of the
TRPV1 receptor. Sensitization may occur in several
ways such as modifications in gating properties of
the ion channel, increased trafficking of the receptor
to cell membrane or increased production of the
TRPV1 protein.22 In the dura mater whole mount
preparations of lean and obese animals, in accord
with previous data,45,53 the density and distribution
of TRPV1- and CGRP-immunoreactive nerve fibers
were similar. It is noteworthy that microscopic
examination revealed characteristic structural
changes in dural afferents of diet-induced obese ani-
mals. The pearl-like appearance of CGRP-
immunoreactivity might be the morphological corre-
late of enhanced CGRP release.54,55 Despite the
known limitations of immunohistochemistry to
detect subtle changes in receptor protein content,
our findings indicate that obesity-associated potentia-
tion of capsaicin-induced neurogenic sensory vasodi-
latation was brought about in the absence of
obvious changes in TRPV1-immunoreactivity of
dural afferents. Sensitization of the TRPV1 receptor
is more likely the consequence of the release of
proinflammatory agents produced in the adipose tis-
sue,56 which may also influence neuropeptide-
mediated vascular reactions. Indeed, we measured
increased plasma concentrations of the proinflamma-
tory cytokines IL-1b and IL-6 in obese animals. IL-
1b may directly modify the gating properties of
TRPV1 to noxious stimuli in primary sensory neu-
rons while leaving the recruitment of the channel to
plasma membrane unaffected.57 Additionally, IL-1b
has been shown to enhance basal and capsaicin-
induced CGRP release in the rat trigeminal ganglion
neurons,58,59 whereas the intraplantar injection of
this cytokine augmented the capsaicin-induced neu-
rogenic sensory vasodilatation without altering the
vascular action of CGRP.60 In the trigeminal gangli-
on, IL-1b has also been demonstrated to increase
the production of prostaglandin E2,
59 which may
lower the heat activation threshold of TRPV1 and
increase capsaicin-evoked responses in sensory neu-
rons61-63 as well as the release of CGRP in slices of
the trigeminal nucleus caudalis.64 IL-6 in conjunction
with its soluble receptor (sIL-6R) may have abilities
to reduce heat threshold and increase heat-activated
inward currents in rat dorsal root ganglion cells with
a possible involvement of TRPV1.65 Both IL-1b and
IL-6/sIL-6R complex have been found to potentiate
heat-stimulated CGRP release from an in vitro rat
skin preparation.66 The obesity-related enhancement
in systemic and cerebral oxidative stress along with
the marked hyperinsulinemia might also contribute
to changes in TRPV1-mediated trigeminovascular
responses.67,68 A major role of the proinflammatory
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cytokine tumor necrosis factor a (TNFa) is not very
likely since its serum level was not affected in our
diet-induced obesity model.35 This, however, does
not exclude the involvement of local TNFa produc-
tion in meningeal TRPV1 sensitization.69
The particular combination of high-fat chow
and sucrose solution applied in this study seems to
be a reliable method to correspond certain criteria
of both experimental and human obesity. However,
it remains unclear whether the present findings are
specific to dietary factors or whether they can be
attributed to the obese state itself regardless of the
etiology. This uncertainty associated with animal
models of diet-induced obesity should be taken into
consideration when interpreting the data.
Sex-related differences affecting the distribu-
tion and metabolic function of adipose tissue may
modify the effect of diet-induced obesity on noci-
ceptor function in females.70 Additionally, the
female sex hormone estradiol may modify nocicep-
tor function by acting directly on the TRPV1 ion
channel or by increasing its expression in dorsal
root ganglion neurons.71 Since this study was under-
taken exclusively in male rats, extrapolation of the
findings to females requires some caution.
Obesity and TRPV1 receptor function may
have a versatile connection. Recent experimental
results attributed a potential therapeutic effect of
TRPV1 receptor stimulation in obesity since capsai-
cin dose-dependently increased intracellular calci-
um concentration in preadipocytes that inhibited
their differentiation.72
Considering the central role of chemosensitive
trigeminal afferents in the pathomechanism of
headaches, both TRPV1 receptor agonists (desensi-
tizing the channel protein) and antagonists have
potential in migraine therapy. A novel approach to
modulate TRPV1 receptor function may be the
development of drugs preventing the phosphoryla-
tion of the receptor, thereby counteracting the
increased probability of channel opening. There-
fore, kinase inhibitors preventing the sensitization
of the receptor may provide a promising strategy
for migraine therapy, especially in obese persons,
where altered TRPV1 receptor function seems to
be an important pathophysiological factor.22,73
In conclusion, our study demonstrates that obe-
sity induced by long-term HFHS feeding increases
TRPV1-mediated CGRP release and neurogenic
sensory vasodilatation in the dura mater encephali
of rats. Augmented trigeminovascular responses on
TRPV1 activation occur without obvious changes in
TRPV1- and CGRP-immunoreactivity of meningeal
nociceptors. HFHS diet-induced obesity also results
in enhanced capsaicin-induced vasoconstriction,
which may also be of relevance to obesity-headache
relationship. The enhanced vasoconstrictor activity
of meningeal blood vessels may impair the effective
removal of pain-producing tissue mediators involved
in the induction or aggravation of headache attacks
or may delay the restoration of tissue homeostasis.
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